On Board with Good Business

ecent revelations that board members of major international arts organizations own companies that are allegedly involved in the pharmaceutical opioid crisis, produce spying software or chemical weapons, though shocking, should not come as a surprise. In today’s economy, arts funding is hard to come by, and museums are hard-pressed to raise critical financing for their programs. While it would be foolish for such institutions to decline gifts from wealthy donors, these problems could perhaps be avoided if museums concentrated less on snagging low-hanging